Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
Public ClinicalTrials.gov record NCT02030301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1/2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 Therapeutic DNA Vaccines in Symptomatic HSV-2-Seropositive Adults
Study identification
- NCT ID
- NCT02030301
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Vical
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- VCL-HB01 Biological
- VCL-HM01 Biological
- PBS Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2013
- Primary completion
- May 31, 2015
- Completion
- Jan 31, 2016
- Last update posted
- Feb 26, 2019
2013 – 2016
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Vaccine Research Clinic | Birmingham | Alabama | 35294 | — |
| Broward Research Group | Hollywood | Florida | 33024 | — |
| Indiana University Infectious Diseases Research | Indianapolis | Indiana | 46202 | — |
| Westover Heights Clinic | Portland | Oregon | 97210 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| University of Utah - Division of Infectious Diseases | Salt Lake City | Utah | 84132 | — |
| University of Washington Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02030301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02030301 live on ClinicalTrials.gov.